NeuroSearch A/S - rights issue - admission to trading and official listing of subscription rights


Copenhagen, 19 October 2009

NeuroSearch A/S - rights issue - admission to trading and official listing of   
subscription rights                                                             

Subscription rights in NeuroSearch A/S have been admitted to trading and        
official listing on NASDAQ OMX Copenhagen as per 22 October 2009. As at the same
date, ISIN code DK0010224666 (NEUR) will be traded exclusive of T-ret           
(subscription rights).                                                          

ISIN: DK0060192698

Name: NeuroSearch T-ret

Proportion: 7:3

Shareholders in NeuroSearch will have the right
to subscribe for 3 new shares per 7 existing   
shares                                         

Trade in subscription rights (both days     22 October 2009 - 4 November 2009
at 5 
included):                                  pm 
                                            (Danish time) 

Orderbook ID: 70232

Orderbook Code: NEUR T

NeuroSearch offers a maximum of 7,387,641 new shares of DKK 20 nominal value    
each at DKK 60 per share with preemptive rights to existing shareholders at the 
ratio of 7:3. Thus shareholders in NeuroSearch will have the right to subscribe 
for 3 new shares per 7 existing shares. Subscription period: 27 October - 9     
November 2009 at 5 pm (Danish time).                                            

Please note:                                                                    
Subscription of new shares will take place in a temporary ISIN (DK0060192771)   
which will not be admitted to trading and official listing on NASDAQ OMX        
Copenhagen. The new shares will be traded in the existing ISIN code DK0010224666
after the registration of the new shares with the Danish Commerce and Companies 
Agency. The changes are expected to be implemented on NASDAQ OMX Copenhagen 13  
November 2009.                                                                  

For further information, please see the prospectus and announcements published  
by the company.                                                                 

For further information, please contact: Simon Søberg Jørgensen, Surveillance,  
tel. +45 33 93 33 66

Attachments

neurosearch - t-retter  uk.pdf